Company: PTHS
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001753926-25-000503
Chunk: 93

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 93
---
 activities or any future sales, marketing, or distribution activities.  

We
may not have sufficient financial or other resources to adequately conduct such litigation or proceedings. Some of our competitors
may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial
resources. Accordingly, despite our efforts, we may not be able to prevent third parties from infringing, misappropriating, or
successfully challenging our intellectual property rights. Uncertainties resulting from the initiation and continuation of patent
litigation or other proceedings could have a material adverse effect on our ability to compete in the marketplace.

Changes
in United States patent law and its administrative and judicial interpretation could diminish the value of patents in general,
thereby impairing our ability to protect our compounds.

Patent
reform legislation could increase the uncertainties and costs surrounding the prosecution of patent applications and the enforcement
or defense of issued patents. As patent reform legislation can inject serious uncertainty into the patent prosecution and litigation
processes, it is not clear what impact future patent reform legislation will have on the operation of our business. However, such
future legislation, and its implementation, could increase the uncertainties and costs surrounding the prosecution of our patent
applications and the enforcement or defense of any issued patents, all of which could have a material adverse effect on our business,
financial condition, results of operations and prospects.

Moreover,
the patent positions of companies engaged in the development and commercialization of pharmaceuticals are particularly uncertain.
We cannot assure you that our efforts to seek patent protection for CC8464, CT2000, CT3000 and future new compounds will not be
negatively impacted by the future court decisions or changes in guidance or procedures issued by the USPTO. These decisions, and
any guidance issued by the USPTO (or changes thereto), could have a material adverse effect on our existing patent portfolio and
our ability to protect and enforce our intellectual property rights in the future.

Intellectual
property rights and regulatory exclusivity rights do not necessarily address all potential threats.

The
degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have
limitations and may not adequately protect our business or permit us to maintain our competitive advantage. For example:

    ●
    others may be able
    to make products that are similar to our current and future new compound but that are not covered by the claims of our current
    patents or of patents that we may own or license in the future;

    ●